Table 2. Liver cancer precursor and cirrhosis cohorts used for Oncomine® Research Edition based analysis of TGF-β1 and TGF-β2 expression.
No. of cohort in Supplementary Figure 3 B + C | Publication | Reference Tissue |
---|---|---|
8 | Mas Liver, Mol Med. 2008 [78] | Cirhosis vs. normal |
9 | Wurmbach Liver, Hepatology 2007 [80] | Cirhosis vs. normal |
10 | Wurmbach Liver, Hepatology 2007 [80] | Dysplasia vs. normal |
11 | Chiang Liver 2, Cancer Res.2008 [81] | HCC vs. Liver Cancer Type: Liver Cancer Precursor |
12 | Mas Liver, Mol Med. 2008 [78] | HCC vs. Liver Cancer Type: Liver Cancer Precursor |
13 | Archer Liver, Cancer Epidemiol Biomarkers Prev. 2009 [82] | HCC vs. Liver Cancer Type: Liver Cancer Precursor |
14 | Chen Liver. Mol Biol Cell. 2002 [76] | HCC vs. Liver Cancer Type: Liver Cancer Precursor |
Number of the respective cohorts in Supplementary Figure 3B and 3C as well as the respective publications and reference tissues are given.